Endocyte, Inc. (ECYT) Posts Q1 Loss of 11c/Share

Endocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.24 million.

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'